Antibiotics no help for mysterious lung-scarring disease, large trial finds

(University of Virginia Health System) The findings dash hopes that antimicrobials would benefit patients with life-threatening idiopathic pulmonary fibrosis. The trial, however, will still benefit the battle against the deadly lung disease, the researchers say.